Alliance for Pandemic Preparedness
March 4, 2020
Broad Spectrum Antiviral Agent Niclosamide and Its Therapeutic Potential
Category: Article Summary
Topic: Clinical Characteristics and Health Care Setting
- Xu et al discuss the potential clinical use of niclosamide, an FDA-approved anthelminthic, in treating COVID-19.
Xu et al. (Mar 3, 2020). Broad Spectrum Antiviral Agent Niclosamide and Its Therapeutic Potential. ACS Infect Dis. https://doi.org/10.1021/acsinfecdis.0c00052